144 related articles for article (PubMed ID: 19048116)
1. Tumor progression and oncogene addiction in a PDGF-B-induced model of gliomagenesis.
Calzolari F; Appolloni I; Tutucci E; Caviglia S; Terrile M; Corte G; Malatesta P
Neoplasia; 2008 Dec; 10(12):1373-82, following 1382. PubMed ID: 19048116
[TBL] [Abstract][Full Text] [Related]
2. Role of Btg2 in the progression of a PDGF-induced oligodendroglioma model.
Appolloni I; Curreli S; Caviglia S; Barilari M; Gambini E; Pagano A; Malatesta P
Int J Mol Sci; 2012 Nov; 13(11):14667-78. PubMed ID: 23203087
[TBL] [Abstract][Full Text] [Related]
3. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
4. PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors.
Appolloni I; Calzolari F; Tutucci E; Caviglia S; Terrile M; Corte G; Malatesta P
Int J Cancer; 2009 May; 124(10):2251-9. PubMed ID: 19165863
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of platelet-derived growth factor associated protein-1 is associated with PDGF-B mediated glioma progression.
Sharma VK; Singh A; Srivastava SK; Kumar V; Gardi NL; Nalwa A; Dinda AK; Chattopadhyay P; Yadav S
Int J Biochem Cell Biol; 2016 Sep; 78():194-205. PubMed ID: 27448842
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma.
Doucette T; Yang Y; Zhang W; Fuller GN; Suki D; Fults DW; Rao G
Int J Cancer; 2011 Nov; 129(9):2093-103. PubMed ID: 21171016
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R
J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
[TBL] [Abstract][Full Text] [Related]
8. Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling.
Chen Y; Wang Z; Dai X; Fei X; Shen Y; Zhang M; Wang A; Li X; Wang Z; Huang Q; Dong J
Cancer Lett; 2015 Sep; 365(2):174-81. PubMed ID: 26049020
[TBL] [Abstract][Full Text] [Related]
9. PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation.
Jiang Y; Boije M; Westermark B; Uhrbom L
Neoplasia; 2011 Jun; 13(6):492-503. PubMed ID: 21677873
[TBL] [Abstract][Full Text] [Related]
10. RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability.
Westermark UK; Lindberg N; Roswall P; Bråsäter D; Helgadottir HR; Hede SM; Zetterberg A; Jasin M; Nistér M; Uhrbom L
Neuro Oncol; 2011 Dec; 13(12):1277-87. PubMed ID: 21926087
[TBL] [Abstract][Full Text] [Related]
11. SCCRO promotes glioma formation and malignant progression in mice.
Broderick SR; Golas BJ; Pham D; Towe CW; Talbot SG; Kaufman A; Bains S; Huryn LA; Yonekawa Y; Carlson D; Hambardzumyan D; Ramanathan Y; Singh B
Neoplasia; 2010 Jun; 12(6):476-84. PubMed ID: 20563250
[TBL] [Abstract][Full Text] [Related]
12. The methylation status of the platelet-derived growth factor-B gene promoter and its regulation of cellular proliferation following folate treatment in human glioma cells.
Zhou Y; Jin G; Mi R; Dong C; Zhang J; Liu F
Brain Res; 2014 Mar; 1556():57-66. PubMed ID: 24502980
[TBL] [Abstract][Full Text] [Related]
13. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.
Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M
Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719
[TBL] [Abstract][Full Text] [Related]
14. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
[TBL] [Abstract][Full Text] [Related]
15. Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression.
Wang W; Qi L; Tan M; Zhang Z; Du J; Wei X; Yao X
Urol Oncol; 2015 Apr; 33(4):168.e17-27. PubMed ID: 25766258
[TBL] [Abstract][Full Text] [Related]
16. PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2.
Terrile M; Appolloni I; Calzolari F; Perris R; Tutucci E; Malatesta P
BMC Cancer; 2010 Oct; 10():550. PubMed ID: 20939912
[TBL] [Abstract][Full Text] [Related]
17. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
[TBL] [Abstract][Full Text] [Related]
18. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
[TBL] [Abstract][Full Text] [Related]
19. p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3.
Wolf RM; Draghi N; Liang X; Dai C; Uhrbom L; Eklöf C; Westermark B; Holland EC; Resh MD
Genes Dev; 2003 Feb; 17(4):476-87. PubMed ID: 12600941
[TBL] [Abstract][Full Text] [Related]
20. The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats.
Dai C; Lyustikman Y; Shih A; Hu X; Fuller GN; Rosenblum M; Holland EC
Neoplasia; 2005 Apr; 7(4):397-406. PubMed ID: 15967117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
